BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity. (Q30370399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

title

BioGPS: navigating biological space to predict polypharmacology, off-targeting, and selectivity (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Laura Goracci

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Gabriele Cruciani

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

author name string

Simon Cross

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

Massimo Baroni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

language of work or name

English

0 references

publication date

24 January 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

volume

83

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

page(s)

517-532

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

Structural biology and bioinformatics in drug design: opportunities and challenges for target identification and lead discovery

26 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The properties of thermostabilised G protein-coupled receptors (StaRs) and their use in drug discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Chemogenomic approaches to drug discovery: similar receptors bind similar ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Multi-target therapeutics: when the whole is greater than the sum of the parts

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

From single- to multi-target drugs in cancer therapy: when aspecificity becomes an advantage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The multi-targeted kinase inhibitor sorafenib inhibits human cytomegalovirus replication.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Selective optimization of side activities: another way for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Modeling promiscuity based on in vitro safety pharmacology profiling data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Structural genomics of the Thermotoga maritima proteome implemented in a high-throughput structure determination pipeline

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Facilities and methods for the high-throughput crystal structural analysis of human proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

High-throughput crystallography at an affordable cost: the TB Structural Genomics Consortium Crystallization Facility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

A new method to detect related function among proteins independent of sequence and fold homology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Detecting evolutionary relationships across existing fold space, using sequence order-independent profile-profile alignments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Rapid and sensitive sequence comparison with FASTP and FASTA

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Basic local alignment search tool

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

PROSITE: a dictionary of sites and patterns in proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Molecular shape comparisons in searches for active sites and functional similarity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Three-dimensional structure analysis of PROSITE patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Recognition of functional sites in protein structures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Alignment-free ultra-high-throughput comparison of druggable protein-ligand binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

High-throughput virtual screening of proteins using GRID molecular interaction fields

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

A computational procedure for determining energetically favorable binding sites on biologically important macromolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Virtual screening for novel openers of pancreatic K(ATP) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Discovery of novel and cardioselective diltiazem-like calcium channel blockers via virtual screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

FLAP: GRID molecular interaction fields in virtual screening. validation using the DUD data set.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Ligand-based virtual screening and ADME-tox guided approach to identify triazolo-quinoxalines as folate cycle inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

GRID-based three-dimensional pharmacophores I: FLAPpharm, a novel approach for pharmacophore elucidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

GRID-based three-dimensional pharmacophores II: PharmBench, a benchmark data set for evaluating pharmacophore elucidation methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Virtual Fragment Screening: Discovery of Histamine H3 Receptor Ligands Using Ligand-Based and Protein-Based Molecular Fingerprints

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Human cytomegalovirus inhibitor AL18 also possesses activity against influenza A and B viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

PocketPicker: analysis of ligand binding-sites with shape descriptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

In silico elucidation of the molecular mechanism defining the adverse effect of selective estrogen receptor modulators

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

High-dose oral tamoxifen, a potential multidrug-resistance-reversal agent: phase I trial in combination with vinblastine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Effect of the anti-breast cancer drug tamoxifen on Ca(2+) movement in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Dual effect of tamoxifen, an anti-breast-cancer drug, on intracellular Ca(2+) and cytotoxicity in intact cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Chemical proteomic profiles of the BCR-ABL inhibitors imatinib, nilotinib, and dasatinib reveal novel kinase and nonkinase targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The structure of the leukemia drug imatinib bound to human quinone reductase 2 (NQO2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Nilotinib as front-line treatment for patients with chronic myeloid leukemia in early chronic phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Imatinib as a paradigm of targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

A selective inhibitor of p38 MAP kinase, SB202190, induced apoptotic cell death of a lipopolysaccharide-treated macrophage-like cell line, J774.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The evolution of protein kinase inhibitors from antagonists to agonists of cellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Identification of novel p38alpha MAP kinase inhibitors using fragment-based lead generation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

An overview on biological mechanisms of PPARs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

The PPARs: from orphan receptors to drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Structural Insights into Human Peroxisome Proliferator Activated Receptor Delta (PPAR-Delta) Selective Ligand Binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Discovery of Novel Inhibitors of the NorA Multidrug Transporter ofStaphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FPROT.24753

Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation

21 January 2018

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Multitarget drugs: the present and the future of cancer therapy

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Cyclic nucleotide phosphodiesterase activity in the quail oviduct: hormonal regulation and involvement in estrogen-induced growth

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Multi-Target Approaches in Colon Cancer Chemoprevention Based on Systems Biology of Tumor Cell-Signaling.

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Functional classification of protein kinase binding sites using Cavbase

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Ligand-, structure- and pharmacophore-based molecular fingerprints: a case study on adenosine A1, A2A, A2B, and A3 receptor antagonists

2 references

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

11 September 2024

https://opencitations.net/index/api/v1/citations/10.1007/S10822-012-9612-8

Image analysis using mathematical morphology.

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Structural genomics. Tapping DNA for structures produces a trickle

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Computational approaches to identifying and characterizing protein binding sites for ligand design

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Nomenclature Committee of the International Union of Biochemistry and Molecular Biology (NC-IUBMB). Enzyme Nomenclature. Recommendations 1992. Supplement 4: corrections and additions (1997).

1 reference

11 September 2024

https://opencitations.net/index/api/v1/references/10.1002/PROT.24753

Identifiers

DOI

10.1002/PROT.24753

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25556939%20AND%20SRC:MED&resulttype=core&format=json

26 February 2020

1 reference